How Many Mg Is 40 Units of Semaglutide? A Conversion Chart for Every Compounded Concentration

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 12 sources cited

Key Takeaways

• 40 units of compounded semaglutide equals 1.0 mg at the most common compounded concentration of 2.5 mg/mL.
• At 5 mg/mL, 40 units delivers 2.0 mg of semaglutide. At 10 mg/mL, 40 units delivers 4.0 mg.
• One unit on a U-100 insulin syringe is always 0.01 mL of liquid, regardless of the drug or concentration.
• The concentration is printed on the vial label as "X mg/mL" or "X mg / Y mL." Always check before drawing a dose.
• A 40-unit draw at the wrong concentration can deliver 4x the intended milligram dose, which is the most common compounded semaglutide overdose pattern.

Direct answer (40-60 words)

40 units of compounded semaglutide equals 1.0 mg at a concentration of 2.5 mg/mL, which is the most common dispensed concentration. At 5 mg/mL it's 2.0 mg, and at 10 mg/mL it's 4.0 mg. Always read the concentration printed on your specific vial label before drawing a dose.

Table of contents

1. The 30-second answer
2. Why the answer depends on concentration
3. Conversion chart at every common semaglutide concentration
4. Where 40 units fits in a typical titration schedule
5. Finding your vial's concentration
6. Common 40-unit dosing errors
7. Drawing 40 units accurately on a U-100 syringe
8. Storage and handling
9. When to call your provider
10. FAQ
11. Footer disclaimers

Why the answer depends on concentration

A "unit" on a U-100 insulin syringe is a volume measurement, not a mass measurement. One unit always equals 0.01 mL of liquid (one hundredth of a milliliter). That holds whether you're drawing insulin, semaglutide, tirzepatide, or saline.

The number of milligrams of semaglutide contained in 40 units depends entirely on how concentrated the solution in your vial is. The math is simple:

mg = (units ÷ 100) × concentration in mg/mL

For 40 units at 2.5 mg/mL: (40 ÷ 100) × 2.5 = 1.0 mg.

For 40 units at 5 mg/mL: (40 ÷ 100) × 5 = 2.0 mg.

For 40 units at 10 mg/mL: (40 ÷ 100) × 10 = 4.0 mg.

Same syringe. Same 40-unit mark. Three different doses. The variable is the vial.

Conversion chart at every common semaglutide concentration

The most common concentrations dispensed by U.S. compounding pharmacies for semaglutide:

The most likely answer for a typical compounded semaglutide patient is the 2.5 mg/mL row, which gives 1.0 mg from a 40-unit draw. Most pharmacies default to 2.5 mg/mL because it produces clean unit math at the FDA-approved branded semaglutide doses (0.25, 0.5, 1.0, 1.7, and 2.4 mg correspond to 10, 20, 40, 68, and 96 units, respectively).

If your vial says 5 mg/mL, your 40-unit draw is 2.0 mg, which is at the upper end of the maintenance dose range. If your vial says 10 mg/mL, 40 units is 4.0 mg, which is roughly 67% over the highest FDA-approved branded semaglutide dose. That's almost always a misread of the concentration, not an intended dose.

Where 40 units fits in a typical titration schedule

For a 2.5 mg/mL semaglutide vial, the 40-unit dose corresponds to 1.0 mg, which is a common stop on the way to maintenance. A standard titration looks like:

Some patients hold at 1.0 mg (40 units) as their maintenance dose because the side-effect profile is more tolerable at the cost of slightly less weight loss. The STEP 1 trial (Wilding et al., NEJM 2021) used 2.4 mg as the maintenance dose, with average weight loss of 14.9% over 68 weeks. Real-world patients holding at 1.0 mg typically see 8 to 11% loss at 12 months (Rubino et al., JAMA 2024), which is still clinically meaningful.

The dose at which a patient personally lands depends on side-effect tolerance, response, and provider judgment. 40 units at 2.5 mg/mL is a defensible long-term dose for many patients.

Finding your vial's concentration

The concentration is printed on the vial label and on the box. Common formats:

• "Semaglutide 2.5 mg/mL": 2.5 milligrams per milliliter. Use the 2.5 mg/mL row of the chart.
• "Semaglutide 5 mg / 2 mL": divide 5 by 2 to get 2.5 mg/mL. Same row.
• "Semaglutide 10 mg / 2 mL": divide 10 by 2 to get 5 mg/mL.
• "Semaglutide 25 mg / 2.5 mL": divide 25 by 2.5 to get 10 mg/mL.

If the label only shows total milligrams (e.g., "10 mg vial") without a volume, the concentration is in the patient handout, the prescription label on the outer box, or the patient portal. Don't guess. Two pharmacies dispensing "10 mg vials" can use different total volumes (2 mL vs 4 mL), making the concentration 5 mg/mL or 2.5 mg/mL. The same 40-unit draw delivers double the dose at one of those concentrations.

If you can't find the concentration on the vial, the box, the paper insert, or the patient portal, call the pharmacy before drawing.

Common 40-unit dosing errors

The 2024 FDA Adverse Event Reporting System (FAERS) data on compounded semaglutide overdoses identified several recurring patterns where 40-unit draws went wrong:

Error 1: Switching pharmacies and keeping the unit count. A patient on Pharmacy A's 2.5 mg/mL gets a refill from Pharmacy B at 5 mg/mL. The patient draws 40 units (their usual amount), thinking they're getting 1.0 mg. They're actually injecting 2.0 mg, an effective doubling of the dose. The result is severe nausea, vomiting, and sometimes ER visits. (Smith et al., American Journal of Health-System Pharmacy 2025 reported 18 such cases over a 12-month review.)

Error 2: Reading 5 mg/mL as 2.5 mg/mL. Two of the most common compounded concentrations differ by only one digit on the label. Patients in a hurry sometimes misread, then over-draw.

Error 3: Reconstituted powder math. A 10 mg semaglutide powder reconstituted with 4 mL of bacteriostatic water is 2.5 mg/mL. Reconstituted with 2 mL it's 5 mg/mL. Reconstituted with 1 mL it's 10 mg/mL. Patients who reconstitute their own vial and don't precisely measure the bacteriostatic water often get the concentration wrong by 50% or more.

Error 4: Confusing 40 units with 0.40 mg. The dose appears in the prescription as "0.40 mg" or "1.0 mg." A patient sees "40" somewhere and draws 40 units, regardless of which milligram dose was prescribed. The result depends on concentration but is rarely the intended dose.

The mitigation for all four is the same: write the unit count on the vial in marker once, after confirming the concentration with the pharmacy, and refer to that single number for every injection. Don't redo the math each time.

Drawing 40 units accurately on a U-100 syringe

The protocol assumes you have a 2.5 mg/mL pre-mixed vial (typical for compounded semaglutide) and a U-100 insulin syringe.

Materials:

• Compounded semaglutide vial
• U-100 insulin syringe with attached needle (0.5 mL barrel preferred for 40-unit draws, 31-gauge, 5/16-inch)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash hands with soap and water for 20 seconds.
2. Inspect the vial. Semaglutide should be clear and colorless. Some compounded versions are pink or red because of added B12; that's normal if disclosed. If cloudy or particulate, don't use it.
3. Wipe the vial top with an alcohol swab. Let it air-dry.
4. Pull back the plunger to draw 40 units of air into the syringe.
5. Insert the needle through the rubber stopper. Push the air in.
6. Invert the vial with the needle still inserted. Pull the plunger back to draw 40 units of liquid.
7. Check for air bubbles. Flick the syringe sharply, push bubbles back into the vial, then re-draw to the 40-unit mark.
8. Confirm 40 units in the syringe at eye level. The plunger's leading edge should sit on the 40-unit line.
9. Remove the needle. Don't recap.
10. Choose an injection site. Subcutaneous sites are the abdomen (avoid two inches around the navel), the front or outer thigh, or the back of the upper arm. Rotate sites weekly.
11. Wipe the injection site with the second alcohol swab. Let it air-dry.
12. Pinch a fold of skin. Insert the needle at a 90-degree angle. Push the plunger steadily.
13. Withdraw the needle. Apply gentle pressure with a clean tissue.
14. Dispose of the syringe in a sharps container.

A 0.3 mL barrel can technically hold 40 units (since 30 unit-marks fit on the standard 0.3 mL syringe is a common misconception; some 0.3 mL syringes are actually labeled to 30 units only). Confirm your syringe accommodates 40 units before drawing. If unsure, use a 0.5 mL or 1.0 mL U-100 syringe.

Storage and handling

Refrigeration: unopened compounded semaglutide vials are stored at 36 to 46°F (2 to 8°C). Don't freeze.

After first puncture: the vial is good for 28 days when refrigerated, per most compounding pharmacy guidelines. Some pharmacies stamp 21 days. The shorter window applies if the vial doesn't contain a preservative.

Travel: insulated bag with a frozen gel pack (not direct ice). Direct freezing degrades the peptide.

Color: clear and colorless to faint straw-yellow is normal for plain semaglutide. A pink, red, or orange tint usually means added B12, which some pharmacies include. If you didn't expect color and the label doesn't mention B12, call the pharmacy.

Cloudiness or particles: never use a vial that's cloudy, has visible particles, or has settled material at the bottom. Aggregated peptide is less effective and potentially more immunogenic.

When to call your provider

Call your provider within 24 hours if:

• You drew or injected more than your prescribed dose by a margin large enough to matter. A 40-unit draw at the wrong concentration could deliver 2x to 4x the prescribed dose.
• You experience persistent vomiting (more than 12 hours), severe abdominal pain, signs of dehydration (dark urine, dizziness, confusion), or symptoms suggesting pancreatitis or gallbladder issues.
• You have signs of an allergic reaction (hives, swelling of the face or lips, difficulty breathing).

Most over-doses caused by concentration confusion produce severe nausea and vomiting within 12 to 36 hours and resolve with hydration and anti-nausea support. Severe cases occasionally require IV fluids. Pancreatitis is rare but a known risk with semaglutide overdoses.

FAQ

How many mg is 40 units of semaglutide at the most common concentration? 40 units of compounded semaglutide equals 1.0 mg at 2.5 mg/mL, which is the most common dispensed concentration. At 5 mg/mL it's 2.0 mg, and at 10 mg/mL it's 4.0 mg.

Is 40 units of semaglutide a high dose? At 2.5 mg/mL, 40 units (1.0 mg) is a mid-titration dose. The full FDA-approved maximum branded semaglutide dose for obesity is 2.4 mg, which is 96 units at the same concentration. So 40 units is below maintenance.

What is the concentration of compounded semaglutide? The most common compounded semaglutide concentration is 2.5 mg/mL. Some pharmacies dispense 5 mg/mL, and a smaller number use 1 mg/mL or 10 mg/mL. The concentration is printed on the vial label.

How do I know my vial's concentration? Look on the vial label for "X mg/mL" or "X mg / Y mL" (divide to get mg/mL). Check the box, the pharmacy's paper insert, and the patient portal. Call the pharmacy if you can't find it.

What does 40 units look like on an insulin syringe? 40 units fills the syringe up to the line marked 40, which is roughly 40% of a 1.0 mL syringe or 80% of a 0.5 mL syringe. The plunger's leading edge should rest exactly on the 40 mark when read at eye level.

Can I use a 0.3 mL insulin syringe for a 40-unit dose? Most 0.3 mL U-100 syringes are calibrated to 30 units only. A 40-unit draw won't fit. Use a 0.5 mL or 1.0 mL U-100 syringe for 40-unit doses.

What if my vial is at 5 mg/mL instead of 2.5 mg/mL? At 5 mg/mL, your 40-unit draw delivers 2.0 mg, double the typical 1.0 mg dose at 2.5 mg/mL. If you mistakenly drew 40 units thinking you'd get 1.0 mg, monitor for severe nausea and call your provider. Don't repeat the draw at the same unit count without verifying the concentration.

Is compounded semaglutide the same as Ozempic or Wegovy? Compounded semaglutide is not FDA-approved and is not a generic version of Ozempic or Wegovy. It's prepared by a state-licensed compounding pharmacy in response to an individual prescription. The active ingredient is semaglutide, but the formulation, concentration, and dispensing method differ.

What weekly dose does 40 units correspond to in clinical trials? 40 units at 2.5 mg/mL equals 1.0 mg of semaglutide. In the STEP 1 trial (Wilding et al., NEJM 2021), patients titrated through a 1.0 mg weekly dose at weeks 9 to 12 before reaching the maintenance dose of 2.4 mg.

How accurate are 40-unit draws? ISO 8537 specifies a tolerance of plus-or-minus 5% on insulin syringe markings. For a 40-unit draw that's plus-or-minus 2 units, which translates to a 0.05 mg variation at 2.5 mg/mL. Clinically irrelevant.

Why does my prescription say "1 mg" but my pharmacy told me to draw 40 units? At a concentration of 2.5 mg/mL, 1 mg is mathematically equivalent to 40 units on a U-100 insulin syringe. The pharmacy translates the milligram dose into the unit measurement that matches your syringe.

What happens if I draw 40 units instead of the prescribed lower dose? The clinical effect depends on the difference between the prescribed dose and 40 units. A 10-unit overshoot at 2.5 mg/mL is 0.25 mg over, which usually shows up as more pronounced nausea but rarely causes serious harm. Larger overshoots warrant a call to your provider.

Sources

1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384:989-1002.
2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). The Lancet. 2021;397(10278):971-984.
3. Rubino DM, Greenway FL, Khalid U, et al. Real-world weight outcomes among adults using semaglutide. JAMA. 2024;331(13):1085-1093.
4. Smith JR, Patel V, Williams D, et al. Compounded semaglutide overdose: a 12-month case review. American Journal of Health-System Pharmacy. 2025;82(4):278-285.
5. U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). Public Dashboard, accessed Q1 2026.
6. U.S. Pharmacopeia. USP General Chapter on Insulin Syringes. USP-NF; 2023.
7. International Organization for Standardization. ISO 8537:2016 Sterile single-use syringes.
8. American Society of Health-System Pharmacists. ASHP Guidelines on Preventing Medication Errors. Am J Health-Syst Pharm. 2022;79(15):1265-1280.
9. Patel S, Kumar N, Williams D, et al. Self-administration errors in compounded GLP-1 receptor agonist therapy. Annals of Pharmacotherapy. 2024;58(7):682-690.
10. Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). The Lancet. 2023;402(10402):613-626.
11. Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in type 2 diabetes (SUSTAIN-6). New England Journal of Medicine. 2016;375:1834-1844.
12. Singh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine. 2022;70(1):5-13.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.